SENS - Senseonics Holdings Stock Price - Barchart.com
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
or
Faster, Cleaner, Better.

Senseonics Holdings (SENS)

Senseonics Holdings (SENS)
0.4619 -0.0075 (-1.60%) 10/08/25 [NYSE Arca]
0.4700 x 200 0.4740 x 700
Realtime by (Cboe BZX)
0.4700 x 200 0.4740 x 700
Realtime 0.4740 +0.0121 (-) 19:36 ET
Quote Overview for Wed, Oct 8th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
0.4590
Day High
0.4876
Open 0.4800
Previous Close 0.4694 0.4694
Volume 11,382,287 11,382,287
Average Volume 9,575,910 9,575,910
Relative Strength 49.86 49.86
Weighted Alpha -42.81 -42.81
5-Day Change +0.0490 (+11.87%) +0.0490 (+11.87%)
52-Week Range 0.2500 - 1.4000 0.2500 - 1.4000
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 382,411
  • Shares Outstanding, K 814,681
  • Annual Sales, $ 22,470 K
  • Annual Income, $ -78,620 K
  • EBIT $ -65 M
  • EBITDA $ -63 M
  • 60-Month Beta 0.83
  • Price/Sales 20.48
  • Price/Cash Flow N/A
  • Price/Book 3.90
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.10
  • Most Recent Earnings $-0.02 on 08/06/25
  • Next Earnings Date 11/06/25
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical Information Systems

Options Overview Details

View History
  • Implied Volatility 170.53% ( +29.12%)
  • Historical Volatility 87.33%
  • IV Percentile 74%
  • IV Rank 38.75%
  • IV High 378.98% on 11/14/24
  • IV Low 38.63% on 10/17/24
  • Put/Call Vol Ratio 0.06
  • Today's Volume 1,237
  • Volume Avg (30-Day) 1,637
  • Put/Call OI Ratio 0.11
  • Today's Open Interest 106,049
  • Open Int (30-Day) 95,791

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/25
See More
  • Average Estimate -0.01
  • Number of Estimates 2
  • High Estimate -0.01
  • Low Estimate -0.02
  • Prior Year -0.04
  • Growth Rate Est. (year over year) +75.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.4125 +11.98%
on 10/01/25
Period Open: 0.4436
0.5788 -20.20%
on 10/06/25
+0.0183 (+4.13%)
since 09/08/25
3-Month
0.4125 +11.98%
on 10/01/25
Period Open: 0.4952
0.6289 -26.55%
on 07/17/25
-0.0333 (-6.72%)
since 07/08/25
52-Week
0.2500 +84.76%
on 12/06/24
Period Open: 0.3355
1.4000 -67.01%
on 02/13/25
+0.1264 (+37.68%)
since 10/08/24

Most Recent Stories

More News
Lake Street Remains a Buy on Senseonics Holdings (SENS)

Lake Street analyst Ben Haynor maintained a Buy rating on Senseonics Holdings today and set a price target of $1.00. The company’s shares closed yesterday at $0.57.Elevate Your Investing Strategy: Take...

SENS : 0.4619 (-1.60%)
Analysts Offer Insights on Healthcare Companies: Senseonics Holdings (SENS) and Arcus Biosciences (RCUS)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Senseonics Holdings (SENS – Research Report) and Arcus Biosciences (RCUS – Research Report) with bullish...

SENS : 0.4619 (-1.60%)
RCUS : 15.05 (+7.27%)
Analysts Offer Insights on Healthcare Companies: Senseonics Holdings (SENS) and Arcutis Biotherapeutics (ARQT)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Senseonics Holdings (SENS – Research Report) and Arcutis Biotherapeutics (ARQT – Research Report) with...

SENS : 0.4619 (-1.60%)
ARQT : 21.24 (+3.26%)
Senseonics Announces Preliminary Unaudited Revenue for Third Quarter 2025 and Provides Business Update

Preliminary unaudited revenue of $8.1 million for Q3 2025 Generated record quarterly new patient starts in Q3 2025 Established reverse stock split ratio of 1:20, anticipated to be effective October...

SENS : 0.4619 (-1.60%)
Senseonics Signs Memorandum of Understanding with Ascensia Diabetes Care to Take Over Commercialization and Distribution of Eversense 365

CGM commercial operations to transition from Ascensia Diabetes Care to Senseonics Brian Hansen to be appointed Chief Commercial Officer Non-dilutive debt facility expanded up to $100 million...

SENS : 0.4619 (-1.60%)
HTGC : 17.71 (-1.17%)
Senseonics Holdings, Inc. Reports Second Quarter Financial Results

Generated Q2 revenue of $6.6 million, representing year-over-year growth of 37% Achieved a 79% increase in U.S. new patient starts over prior year GERMANTOWN, Md., Aug. 06, 2025 (GLOBE NEWSWIRE)...

SENS : 0.4619 (-1.60%)
Senseonics Holdings, Inc. Schedules Second Quarter 2025 Earnings Release and Conference Call for August 6, 2025 at 4:30 P.M. Eastern Time

GERMANTOWN, Md., July 16, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable...

SENS : 0.4619 (-1.60%)
Senseonics Holdings, Inc. to Host In-Person and Virtual Analyst Event at ADA 2025: Eversense® 365 Continuous Glucose Monitoring System for People with Diabetes

SENS : 0.4619 (-1.60%)
Senseonics Holdings, Inc. Announces Closing of Public Offering, Including Exercise in Full of the Underwriters’ Option to Purchase Additional Shares, and Closing of Private Placement

SENS : 0.4619 (-1.60%)
Senseonics Announces Pricing of $50 Million Public Offering of Common Stock and Concurrent Private Placement

SENS : 0.4619 (-1.60%)

Business Summary

Senseonics Holdings, Inc. is a medical technology company which focused on the design, development and commercialization of glucose monitoring systems. Senseonics Holdings, Inc. is based in Germantown, United States.

See More

Key Turning Points

3rd Resistance Point 0.5086
2nd Resistance Point 0.4981
1st Resistance Point 0.4800
Last Price 0.4619
1st Support Level 0.4514
2nd Support Level 0.4409
3rd Support Level 0.4228

See More

52-Week High 1.4000
Fibonacci 61.8% 0.9607
Fibonacci 50% 0.8250
Fibonacci 38.2% 0.6893
Last Price 0.4619
52-Week Low 0.2500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar